Researchers evaluated the impact of the timing of COVID-19 infection during pregnancy on both maternal illness severity and pregnancy outcomes.

Participants with schizophrenia, bipolar disorder, or recurrent major depressive disorder were at a 10% higher risk of persistent symptoms.

The revamped open-access site tracks scientific progress toward the development of broadly protective coronavirus vaccines.

Deaths from acute respiratory distress syndrome (ARDS) and sepsis spiked in the US during the COVID pandemic, and ...

Recent global challenges posed by the COVID-19 pandemic have accelerated innovations in mechanical ventilation technology, with research efforts focused on both invasive and non-invasive modalities to ...

Edesa Biotech has shared data from its truncated phase 3 respiratory failure trial, linking the anti-TLR4 antibody to ...

COVID-19 patients who received Humanigen’s monoclonal antibody lenzilumab were 54 percent more likely to survive without needing ventilation over a 28-day period compared to patients who received a ...

Every time we open our mouth we exhale particles that may contain the virus. As states begin to adjust to a new normal and people start spending more time indoors, experts and local officials are ...